Search

Your search keyword '"Grünig, Ekkehard"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Grünig, Ekkehard" Remove constraint Author: "Grünig, Ekkehard" Database ScienceDirect Remove constraint Database: ScienceDirect
40 results on '"Grünig, Ekkehard"'

Search Results

1. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis

2. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

6. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

7. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

9. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

12. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

13. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

14. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

15. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

17. Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension

19. The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications

23. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

31. RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

38. Imatinib Improves Exercise Capacity and Hemodynamics at 24 Weeks as Add-on Therapy in Symptomatic Pulmonary Arterial Hypertension Patients: The IMPRES Study

Catalog

Books, media, physical & digital resources